The Importance of Mehran Score to Predict Acute Kidney Injury in Patients with TAVI: A Large Multicenter Cohort Study

Background: Transcatheter aortic valve implantation (TAVI) has developed as an alternative to surgery for symptomatic high-risk patients with aortic stenosis (AS). An important complication of TAVI is acute kidney injury. The purpose of the study was to investigate if the Mehran Score (MS) could be used to predict acute kidney injury (AKI) in TAVI patients. Methods: This is a multicenter, retrospective, observational study including 1180 patients with severe AS. The MS comprised eight clinical and procedural variables: hypotension, congestive heart failure class, glomerular filtration rate, diabetes, age >75 years, anemia, need for intra-aortic balloon pump, and contrast agent volume use. We assessed the sensitivity and specificity of the MS in predicting AKI following TAVI, as well as the predictive value of MS with each AKI-related characteristic. Results: Patients were categorized into four risk groups based on MS: low (≤5), moderate (6–10), high (11–15), and very high (≥16). Post-procedural AKI was observed in 139 patients (11.8%). MS classes had a higher risk of AKI in the multivariate analysis (HR 1.38, 95% CI, 1.43–1.63, p < 0.01). The best cutoff for MS to predict the onset of AKI was 13.0 (AUC, 0.62; 95% CI, 0.57–0.67), whereas the best cutoff for eGFR was 42.0 mL/min/1.73 m2 (AUC, 0.61; 95% CI, 0.56–0.67). Conclusions: MS was shown to be a predictor of AKI development in TAVI patients.

[1]  S. Emren,et al.  Predictive Value of the Modified Mehran Score for Contrast-Induced Nephropathy After Transcatheter Aortic Valve Implantation. , 2023, Angiology.

[2]  L. Fimiani,et al.  Early acute kidney injury after transcatheter aortic valve implantation: predictive value of currently available risk scores. , 2022, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[3]  B. Prendergast,et al.  2021 ESC/EACTS Guidelines for the management of valvular heart disease. , 2021, European heart journal.

[4]  P. Lemos,et al.  Performance of Prediction Models for Contrast-Induced Acute Kidney Injury after Transcutaneous Aortic Valve Replacement , 2021, Cardiorenal Medicine.

[5]  J. Leipsic,et al.  Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research. , 2021, European heart journal.

[6]  Jeroen J. Bax,et al.  Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research. , 2021, Journal of the American College of Cardiology.

[7]  G. Delle-Karth,et al.  Evaluating the Association between Contrast Medium Dosage and Acute Kidney Injury in Transcatheter Aortic Valve Replacement Using Different Predictive Models , 2020, Journal of clinical medicine.

[8]  P. Stella,et al.  Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation. , 2020, The New England journal of medicine.

[9]  G. Boriani,et al.  Kidney dysfunction and short term all-cause mortality after transcatheter aortic valve implantation. , 2020, European journal of internal medicine.

[10]  P. Stella,et al.  Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation. , 2020, The New England journal of medicine.

[11]  F. Ruschitzka,et al.  Baseline Predictors of Renal Failure in Transcatheter Aortic Valve Implantation. , 2019, The Journal of invasive cardiology.

[12]  Jeroen J. Bax,et al.  Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey. , 2019, Circulation.

[13]  S. Kaul,et al.  2017 ACC Expert Consensus Decision Pathway for Transcatheter Aortic Valve Replacement in the Management of Adults With Aortic Stenosis: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. , 2017, Journal of the American College of Cardiology.

[14]  G. Gargiulo,et al.  Renal dysfunction and transcatheter aortic valve implantation outcomes , 2016, Expert review of cardiovascular therapy.

[15]  A. Taştan,et al.  Predictive Value of the Mehran Score for Contrast-Induced Nephropathy after Transcatheter Aortic Valve Implantation in Patients with Aortic Stenosis , 2016, Cardiorenal Medicine.

[16]  M. Mack,et al.  Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. , 2016, The New England journal of medicine.

[17]  B. Iung,et al.  The modern epidemiology of heart valve disease , 2015, Heart.

[18]  A. Sato,et al.  Effect of the Mehran risk score for the prediction of clinical outcomes after percutaneous coronary intervention. , 2015, Journal of cardiology.

[19]  T. Wahlers,et al.  Acute kidney injury after transcatheter aortic valve implantation. , 2015, Journal of thoracic disease.

[20]  A. Sannino,et al.  Impact of postoperative acute kidney injury on clinical outcomes after transcatheter aortic valve implantation: A meta‐analysis of 5,971 patients , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[21]  Maurice Buchbinder,et al.  Transcatheter aortic-valve replacement with a self-expanding prosthesis. , 2014, The New England journal of medicine.

[22]  L. W. Andersen,et al.  The Nordic Aortic Valve Intervention (NOTION) trial comparing transcatheter versus surgical valve implantation: study protocol for a randomised controlled trial , 2013, Trials.

[23]  Jennifer Taylor,et al.  ESC/EACTS Guidelines on the management of valvular heart disease. , 2012, European heart journal.

[24]  P. Leprince,et al.  Registry of transcatheter aortic-valve implantation in high-risk patients. , 2012, The New England journal of medicine.

[25]  D. Basile,et al.  Pathophysiology of acute kidney injury. , 2012, Comprehensive Physiology.

[26]  R. Lange,et al.  Incidence and predictors of acute kidney injury in patients undergoing transcatheter aortic valve implantation. , 2011, American heart journal.

[27]  B. Carabello Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery , 2011, Current cardiology reports.

[28]  G. Stone,et al.  A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. , 2004, Journal of the American College of Cardiology.

[29]  G. Stone,et al.  Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. , 2005, The American journal of cardiology.

[30]  D. Morris Valve disease. , 1979, Medical times.